| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/01/2002 | US20020103175 Use of mometasone furoate for treating airway passage and lung diseases |
| 08/01/2002 | US20020103174 Prostate cancer prophylaxes and treatment, optionally iwth 2-methoxyestradiol (2-ME) |
| 08/01/2002 | US20020103172 Vitamin d3 derivatives |
| 08/01/2002 | US20020103171 7-and 9- carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 08/01/2002 | US20020103169 Use of anticancer agents of the phenanthridine class having a specific mechanism of action and cancer therapy |
| 08/01/2002 | US20020103167 Method of treating certain eye diseases |
| 08/01/2002 | US20020103166 2-(4-Chlorophenoxy)-2-oxo-1,3,2-oxazaphosphorinane-3-aceto -hydroxamic acid, for example; antiathritic, -tumor, -metastasis, -proliferative and -ulcer agents; multiple sclerosis; vision defects; skin disorders |
| 08/01/2002 | US20020103165 Engineered spray-dried lipid-based microparticles for cellular targeting |
| 08/01/2002 | US20020103164 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 08/01/2002 | US20020103163 Acetylenic sulfonamide thiol TACE inhibitors |
| 08/01/2002 | US20020103162 Use of threo-methylphenidate compounds to enhance memory |
| 08/01/2002 | US20020103160 Self-cross-linking alkyl cellulose derivative, production process therefor, and use thereof |
| 08/01/2002 | US20020103159 Chitosan and a polysaccharide selected from heparin, heparan sulphate manufacture lactating animals, particularly cows; prophylactic or wound healing treatment for mastitis; bacterial barrier; bacteriostats |
| 08/01/2002 | US20020103158 Dinucleoside polyphosphates which facilitate secretory mechanisms, i.e. increasing the hydration of mucus secretions, stimulating the production of mucins and increasing ciliary beat frequency to facilitate clearance |
| 08/01/2002 | US20020103157 Stimulation of tear secretion by administering uridine 5'-triphosphate dinucleotides, cytidine 5'-triphosphate, adenosine 5'-triphosphate or their useful analogs; enhances mucociliary clearance of nasolacrimal duct |
| 08/01/2002 | US20020103151 Methods and compositions for immunomodulation |
| 08/01/2002 | US20020103141 DNA topoisomerase I and cyclooxygenase-2 (COX-2) inhibiting agents |
| 08/01/2002 | US20020103139 Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control |
| 08/01/2002 | US20020103133 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 08/01/2002 | US20020103127 Inhibitors of proteasomal activity for stimulating hair growth |
| 08/01/2002 | US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption |
| 08/01/2002 | US20020103119 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 08/01/2002 | US20020103114 Administering therapeutically effective amount of bactericidal/permeability-increasing protein product to a human suffering from meningococcemia |
| 08/01/2002 | US20020103112 Wound healing and treatment of fibrosis |
| 08/01/2002 | US20020103111 Comprising peptide sequences which mimic the conserved amino acid motif LDTSL of MAdCAM-1 and which have groups bonded to the N- and C- termini; treatment of inflammatory bowel disease |
| 08/01/2002 | US20020103110 System and method for rectal administration of medication for treatment of migraines |
| 08/01/2002 | US20020103106 Methods of inducing ovulation |
| 08/01/2002 | US20020103105 Treatment of male erectile dysfunction |
| 08/01/2002 | US20020102733 Drug delivery system; obtain receptive binding particles, incubate with surface and hydrophilic polymer, incubate with release agent, monitor distribution through biological systems |
| 08/01/2002 | US20020102729 Formulations for electroporation |
| 08/01/2002 | US20020102723 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects |
| 08/01/2002 | US20020102707 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders |
| 08/01/2002 | US20020102685 Novel use of inhibitors of the epidermal growth factor receptor |
| 08/01/2002 | US20020102684 Human phospholipase inhibitor |
| 08/01/2002 | US20020102676 Nucleotide sequences coding membrane proteins for use in cancer therapy |
| 08/01/2002 | US20020102666 PSCA: prostate stem cell antigen and uses thereof |
| 08/01/2002 | US20020102658 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/01/2002 | US20020102657 Binding protein for use as therapeutic tool in the prevention of Infections disease |
| 08/01/2002 | US20020102649 Human transport protein homologs |
| 08/01/2002 | US20020102645 Novel member of the lysyl oxidase gene family |
| 08/01/2002 | US20020102642 Nuclelotide sequences coding preferential protein for use in therapeutic, diagnostic and medical imaging |
| 08/01/2002 | US20020102609 Antagonists of HMG1 for treating inflammatory conditions |
| 08/01/2002 | US20020102603 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/01/2002 | US20020102568 Nucleic acid sensor molecules |
| 08/01/2002 | US20020102552 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |
| 08/01/2002 | US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 08/01/2002 | US20020102537 Retroviral production |
| 08/01/2002 | US20020102317 For accelerating and amplifying the synthesis of thermal shock proteins of cells of living beings |
| 08/01/2002 | US20020102316 Useful for treating snoring |
| 08/01/2002 | US20020102314 Viscous and low alcohol content; be used for delivering |
| 08/01/2002 | US20020102313 Composition for the relief of heat stress |
| 08/01/2002 | US20020102309 Controlled release formulation for administration of an anti-inflammatory naphthalene derivative |
| 08/01/2002 | US20020102307 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 08/01/2002 | US20020102305 Osmotic device containing pseudoephedrine and an H1antagonist |
| 08/01/2002 | US20020102304 Initial dose of medicine is capable of achieving a rapid pharmacological effect, whereas a second dose achieves a prolonged pharmacological effect; for use in counteracting cravings for nicotine-containing tobacco products |
| 08/01/2002 | US20020102303 For oral administration; releases the drug in low pH (e.g., gastric fluid) is bioavailable; for therapy of pain |
| 08/01/2002 | US20020102302 Stabilized sustained release tramadol formulations |
| 08/01/2002 | US20020102300 Pharmaceuticals formulation |
| 08/01/2002 | US20020102299 Triglyceride reducing agent |
| 08/01/2002 | US20020102298 Temperature-sensitive liposomal formulation |
| 08/01/2002 | US20020102296 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 08/01/2002 | US20020102294 Aerosols comprising nanoparticle drugs |
| 08/01/2002 | US20020102292 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
| 08/01/2002 | US20020102291 For topical application |
| 08/01/2002 | US20020102290 Transdermal preparation containing serotonin receptor antagonist |
| 08/01/2002 | US20020102288 Flexible applicator for applying oil-in-water emulsion with improved stability |
| 08/01/2002 | US20020102279 Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties |
| 08/01/2002 | US20020102266 Stable vaccine compositions for parenteral administration, a method for their use, and a process for their preparation |
| 08/01/2002 | US20020102265 For diagnosis and imaging of cancer and tumor tissues |
| 08/01/2002 | US20020102263 Diagnosis and treatment of malignant neoplasms |
| 08/01/2002 | US20020102247 For therapy of hyperproliferative disorders |
| 08/01/2002 | US20020102235 Novel imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus |
| 08/01/2002 | US20020102230 Method for inactivating pathogens |
| 08/01/2002 | US20020102219 Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa |
| 08/01/2002 | US20020101846 Method for adapting a receiver to transmission conditions and a corresponding receiver |
| 08/01/2002 | US20020100854 Furnace mount and method of installation |
| 08/01/2002 | US20020100185 Drying method for selectively removing volatile components from wet coatings |
| 08/01/2002 | DE10104494A1 Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Carotinoide A process for preparing dry powders of one or more carotenoids |
| 08/01/2002 | DE10104097A1 Pharmazeutische Formulierung enthaltend Thienopyrimidine und Nitrate A pharmaceutical formulation comprising thienopyrimidines and nitrates |
| 08/01/2002 | DE10104096A1 Pharmazeutische Formulierung enthaltend Thienopyrimidine und Nitrate A pharmaceutical formulation comprising thienopyrimidines and nitrates |
| 08/01/2002 | DE10104095A1 Pharmazeutische Formulierung enthaltend Pyrazolo [4,3-d]pyrimidine und Nitrate A pharmaceutical formulation comprising pyrazolo [4,3-d] pyrimidines and nitrates |
| 08/01/2002 | DE10103647A1 Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates A process for preparing a pyrazolo (4,3-d) pyrimidine derivative |
| 08/01/2002 | DE10103454A1 Wirkstoffkonzentrate sowie Verfahren zu ihrer Herstellung Concentrates of active substance and process for their preparation |
| 08/01/2002 | DE10103262A1 Arzneimittel gegen Blasenfunktionsstörung Medicines for bladder dysfunction |
| 08/01/2002 | DE10101307A1 Fumarsäurederivate als NF-kappaB-Inhibitor Fumaric acid derivatives as NF-kappaB inhibitor |
| 08/01/2002 | DE10100911A1 Verfahren zur Hormonersatztherapie und dessen Darreichungsform A method for hormone replacement therapy and its dosage form |
| 08/01/2002 | CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2599884A1 Combinations of drugs for the treatment of neoplastic disorders |
| 08/01/2002 | CA2563051A1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | CA2467657A1 Process for determining target function and identifying drug leads |
| 08/01/2002 | CA2442602A1 Probiotic compounds derived from lactobacillus casei strain ke01 |
| 08/01/2002 | CA2436139A1 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | CA2435950A1 Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders |
| 08/01/2002 | CA2435942A1 Use of an isothiocyanate, a thiocyanate or a mixture thereof as depigmenting agent |
| 08/01/2002 | CA2435888A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | CA2435884A1 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative |
| 08/01/2002 | CA2435883A1 Benzylamine analogue |
| 08/01/2002 | CA2435876A1 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers |
| 08/01/2002 | CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use |